Studies on the biosynthesis of the a-glucosidase inhibitor acarbose: Valienamine, a m-c7n unit not derived from the shikimate pathway

63Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Feeding experiments with Actinoplanes sp. SN223/29 showed that 3-amino-5-hydroxy-[7-13C]benzoic acid is not incorporated into acarbose (I). The valienamine moiety of I is thus not derived in the same way, from the shikimate pathway, as the m-C7N units in the ansamycin, mitomycin and ansamitocin antibiotics. Feeding experiments with [U-13C3]-glycerol followed by analysis of I by multiple quantum NMR spectroscopy support this con-clusion and point to formation of the valienamine moiety by cyclization of a heptulose phos-phate which arises from a triose phosphate via successive transfer of two 2-carbon fragments by transketolase, as proposed by pape and co-workers. © 1987, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Degwert, U., van Hulst, R., Pape, H., Herrold, R. E., Beale, J. M., Keller, P. J., … Floss, H. G. (1987). Studies on the biosynthesis of the a-glucosidase inhibitor acarbose: Valienamine, a m-c7n unit not derived from the shikimate pathway. The Journal of Antibiotics, 40(6), 855–861. https://doi.org/10.7164/antibiotics.40.855

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free